A breast biopsy is a simple medical procedure in which a sample of breast tissue is removed and sent to a laboratory for testing. A breast biopsy is the best way to evaluate if a suspicious lump or portion of the breast is cancerous.
The increasing incidences of breast cancer across the world and growing awareness about this disease and treatment, are the most prominent factors escalating the growth of the global Breast Biopsy market. According to World Health Organization, in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years, making it the world’s most prevalent cancer.
Furthermore, other factors include a higher incidence of breast cancer among postmenopausal women. Therefore, countries, where there are higher proportions of women above 40 age group, would be potential markets for breast cancer screening and diagnosis. In addition, new product approvals and launches coupled with growing inclination towards minimally invasive and image-guided needle biopsies such as vacuum-assisted biopsy and core needle biopsy are responsible for the substantial growth of the global Breast Biopsy market during the forecast period.
On the downside, the high cost of the procedure, infection risks associated with breast biopsy procedures, uncertain regulatory issues, and unclear reimbursement policies are the factors hampering the growth of the market.
Covid-19 Impact on Breast Biopsy Market
In addition, the current Breast Biopsy Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Breast Biopsy Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Breast Biopsy Market Segment Overview
According to Product, Core Needle Biopsy (CNB) segment dominated the global Breast Biopsy market and is expected to maintain this trend throughout the forecast period. This is due to the less invasive procedure compared to others and it provides a more definitive diagnosis. Additionally, the use of CNB and ultrasonographic and mammographic guidance is highly accurate for diagnosing breast cancer that increases the growth of the market. Furthermore, by Guided Technology, the Ultrasound Guided Biopsy segment is expected to grow at the highest rate during the forecast period. This is due to the sound waves used instead of ionizing radiation to locate abnormality or lump and is less invasive with reduced scars.
Breast Biopsy Market, By Product
· Vacuum Assisted Biopsy (VAB)
· Core Needle Biopsy (CNB)
· Fine Needle Aspiration Biopsy (FNAB)
Breast Biopsy Market, By Guided Technology
· MRI-Guided Biopsy
· Ultrasound Guided Biopsy
· Mammography Guided Stereotactic Biopsy
· CT-Guided Biopsy
· Others
Breast Biopsy Market, By End User
· Hospitals
· Ambulatory Surgical Centers & Clinics
Breast Biopsy Market Regional Overview
Geographically, the Asia Pacific region is expected to witness the highest growth in the Breast Biopsy market during the forecast period. The healthcare infrastructure in developing countries such as China, India, and South Korea is evolving at a rapid pace, leading to major investments in advanced systems including liquid breast biopsy, and vacuum-assisted biopsy instruments, among others by hospitals and breast care centers. This factor is boosting the growth of the Asia pacific breast biopsy market. Additionally, the growing prevalence of breast cancer, the increasing number of awareness programs for the early detection of breast cancer, and the huge government spending on breast cancer research studies are the other major factors that propelling the growth of the breast biopsy market in Asia Pacific region.
Breast Biopsy Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Breast Biopsy Market, Key Players
· Biomed Diagnostics, Inc.
· Bard Peripheral Vascular Inc.
· F. Hoffmann-La Roche Ltd.
· Hologic Inc.
· Intact Medical
· Mammotome
· OncoCyte Corporation
· Laboratory Corporation of America Holdings (Labcorp)
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Breast Biopsy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Vacuum Assisted Biopsy (VAB)
- 5.2.2. Core Needle Biopsy (CNB)
- 5.2.3. Fine Needle Aspiration Biopsy (FNAB)
- 5.3. Market Analysis, Insights and Forecast – By Guided Technology
- 5.3.1. MRI-Guided Biopsy
- 5.3.2. Ultrasound Guided Biopsy
- 5.3.3. Mammography Guided Stereotactic Biopsy
- 5.3.4. CT-Guided Biopsy
- 5.3.5. Others
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Hospitals
- 5.4.2. Ambulatory Surgical Centers & Clinics
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Breast Biopsy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Vacuum Assisted Biopsy (VAB)
- 6.2.2. Core Needle Biopsy (CNB)
- 6.2.3. Fine Needle Aspiration Biopsy (FNAB)
- 6.3. Market Analysis, Insights and Forecast – By Guided Technology
- 6.3.1. MRI-Guided Biopsy
- 6.3.2. Ultrasound Guided Biopsy
- 6.3.3. Mammography Guided Stereotactic Biopsy
- 6.3.4. CT-Guided Biopsy
- 6.3.5. Others
- 6.4. Market Analysis, Insights and Forecast – By End User
- 6.4.1. Hospitals
- 6.4.2. Ambulatory Surgical Centers & Clinics
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Breast Biopsy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Vacuum Assisted Biopsy (VAB)
- 7.2.2. Core Needle Biopsy (CNB)
- 7.2.3. Fine Needle Aspiration Biopsy (FNAB)
- 7.3. Market Analysis, Insights and Forecast – By Guided Technology
- 7.3.1. MRI-Guided Biopsy
- 7.3.2. Ultrasound Guided Biopsy
- 7.3.3. Mammography Guided Stereotactic Biopsy
- 7.3.4. CT-Guided Biopsy
- 7.3.5. Others
- 7.4. Market Analysis, Insights and Forecast – By End User
- 7.4.1. Hospitals
- 7.4.2. Ambulatory Surgical Centers & Clinics
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Breast Biopsy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Vacuum Assisted Biopsy (VAB)
- 8.2.2. Core Needle Biopsy (CNB)
- 8.2.3. Fine Needle Aspiration Biopsy (FNAB)
- 8.3. Market Analysis, Insights and Forecast – By Guided Technology
- 8.3.1. MRI-Guided Biopsy
- 8.3.2. Ultrasound Guided Biopsy
- 8.3.3. Mammography Guided Stereotactic Biopsy
- 8.3.4. CT-Guided Biopsy
- 8.3.5. Others
- 8.4. Market Analysis, Insights and Forecast – By End User
- 8.4.1. Hospitals
- 8.4.2. Ambulatory Surgical Centers & Clinics
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Breast Biopsy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Vacuum Assisted Biopsy (VAB)
- 9.2.2. Core Needle Biopsy (CNB)
- 9.2.3. Fine Needle Aspiration Biopsy (FNAB)
- 9.3. Market Analysis, Insights and Forecast – By Guided Technology
- 9.3.1. MRI-Guided Biopsy
- 9.3.2. Ultrasound Guided Biopsy
- 9.3.3. Mammography Guided Stereotactic Biopsy
- 9.3.4. CT-Guided Biopsy
- 9.3.5. Others
- 9.4. Market Analysis, Insights and Forecast – By End User
- 9.4.1. Hospitals
- 9.4.2. Ambulatory Surgical Centers & Clinics
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Biomed Diagnostics, Inc.
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Bard Peripheral Vascular Inc.
- 10.6. F. Hoffmann-La Roche Ltd.
- 10.7. Hologic Inc.
- 10.8. Intact Medical
- 10.9. Mammotome
- 10.10. OncoCyte Corporation
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
